university of minnesota medical Center, Fairview

Minneapolis, Minnesota 55455-0363

5 studies enrolling now · 105 studies all time

What they study most

ALL, Childhood, Accelerated Phase Chronic Myelogenous Leukemia, Acute Ischemic Stroke, Acute Kidney Injury, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities

Studies at this site

• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer — Recruiting now
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) — Recruiting now
• Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia — Recruiting now
• Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) — Recruiting now
• Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation — Recruiting now
• Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis — Stopped early
• Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts — Running, not enrolling
• A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib — Running, not enrolling
• Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer — Running, not enrolling
• A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer — Stopped early
• Hemodynamic-GUIDEd Management of Heart Failure — Completed
• Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
• Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma — Stopped early
• Validation of CardioMEMS HF System Cardiac Output Algorithm IDE — Completed
• Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia — Completed
• The ARIES HeartMate 3 Pump IDE Study — Completed
• Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies — Stopped early
• Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study — Completed
• A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation — Stopped early
• Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors — Running, not enrolling
• CentriMag Failure-to-Wean Post Approval Study — Completed
• Extravascular ICD Pivotal Study — Completed
• The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study — Completed
• REmodeling the Left Ventricle With Atrial Modulated Pacing — Completed
• Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) — Stopped early
• Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 — Completed
• Myocardial Ischemia and Transfusion — Completed
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed
• Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia — Completed
• AdaptResponse Clinical Trial — Completed
• Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors — Stopped early
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer — Completed
• Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia — Completed
• Caterpillar™ Arterial Embolization Device Post-Market Study — Completed
• Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS — Completed
• ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed
• Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer — Completed
• SHIELD II Clinical Investigation — Stopped early
• MOMENTUM 3 IDE Clinical Study Protocol — Completed
• Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy — Completed
• MOMENTUM 3 Continued Access Protocol — Completed
• Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma — Completed
• Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma — Completed
• Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma — Completed
• Advanced Reperfusion Strategies for Refractory Cardiac Arrest — Stopped early
• A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes — Stopped early
• Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia — Completed
• Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes — Completed
• Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma — Completed
• A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension — Stopped early